Prostate Cancer

PROSTATE CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

MRI-Based Algorithm More Predictive of Biochemical Recurrence After Prostate Cancer Surgery Than Existing Prognostic Tools

A retrospective study found that a radiomic-clinicopathologic nomogram performed better than other tools in predicting biochemical recurrence-free survival after surgery for prostate cancer.
First GnRH Receptor Antagonist Enters Advanced Prostate Cancer Treatment Portfolio

Daniel J. George, MD, a lead investigator on the HERO study, discusses the implications of relugolix’s approval for advanced prostate cancer.
Use of Commercial Genomic Testing for Prostate Cancer ‘Highly Variable’ in the United States

Investigators evaluated a large sample of commercially insured patients with prostate cancer to assess use of tissue-based gene expression testing.
Biosimilars in Cancer Care: Insights From 2020 and Expectations for 2021

Sean McGowan, senior director of Biosimilars at AmerisourceBergen, and Brian Ansay, senior vice president of Sales and Corporate Services at ION Solutions, review 2020 biosimilar trends in oncology and forecast what is ahead in 2021.
NCI-MATCH Trial Identifies Actionable Alterations in More Than One-Third of Patients With Cancer

Researchers have identified actionable alterations in nearly 38% of patients with cancer, and almost 18% of patients were assigned to treatments based on their molecular profiling results.

Current Research Into Pain Assessment

Immunotherapy for Prostate Cancer

Targeted Agents

Targeted Agents (cont.)

Radium-223

Chemotherapy

Immunotherapy

Treatment Sequencing

Androgen Deprivation Therapy

Duration of ADT

Docetaxel in Combination With ADT

Researchers at Johns Hopkins identified genes involved in tumor cell metabolism that may predict whi

HSD3B1 Allele Inheritance Linked With ADT Resistance

ADT and Radiation

Predictions for the Future

PROSTATE CANCER NEWS

Findings May Guide Use of Salvage Partial Gland Ablation for Recurrent PCa

February 26, 2021

Nurse checking blood pressure.

Cardiovascular Risk Factors Undertreated in Veterans With Prostate Cancer

February 25, 2021

Prostate gland

Prostate Cancer Bone Metastasis Burden Tied to Prostate RT Survival Benefit

February 23, 2021

Men whose castration-resistant prostate cancer has metastasized to the liver have the worst overall

FUS Ablation Feasible for Intermediate-Risk Prostate Cancer

February 19, 2021

Axial T2-weighted image of the prostate demonstrates a focal T2-hypointense tumor (arrow) in the left posterolateral peripheral zone.

MRI May Have a Role in Community-Based Prostate Cancer Screening

February 19, 2021

Next post in Prostate Cancer

Findings May Guide Use of Salvage Partial Gland Ablation for Recurrent PCa